MedTrace Logo

Zinc to Treat Tinnitus in the Elderly

NCT00683644 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2017-12-13

Study results available
· View outcomes & findings →

Summary

There is widespread belief and some evidence to indicate that zinc can successfully treat tinnitus. Zinc deficiency is more likely to occur in the elderly . The primary objective of this study is to establish the effectiveness of zinc for the treatment of tinnitus in individuals 60 years of age and older. Subjects will be randomly assigned to either receive zinc daily or a placebo. After 4 months and a 1-month wash-out, the subjects will be crossed over to the other group.

Conditions

  • Tinnitus

Interventions

DRUG

Zinc

Zinc taken once daily

DRUG

Placebo oral capsule

Placebo capsules taken once daily

Sponsors & Collaborators

  • Tinnitus Research Initiative

    collaborator OTHER

  • University of Iowa

    lead OTHER

Principal Investigators

  • Richard S. Tyler, Ph.D. · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-12-31
Completion
2011-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00683644 on ClinicalTrials.gov